Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2026-03-01
Saila:	JEADV Clinical Practice
Gaiak:	atopic dermatitis biologics JAK inhibitors real‐world evidence
Sarrera elektronikoa:	https://doi.org/10.1002/jvc2.70153
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!